Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
07 2021
Historique:
received: 01 12 2020
revised: 22 03 2021
accepted: 01 04 2021
pubmed: 13 4 2021
medline: 28 7 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

To compare the impact of two radiation modalities on loco-regional control, survival and tumour emergence, after node dissection for an unilateral head and neck carcinoma of unknown primary (HNCUP). This is a multicentric retrospective study of 138 patients with unilateral HNCUP treated between 2002 and 2017. The absence of primary tumour was assessed by a systematic panendoscopy and positron emission tomography. Neck dissection was initially performed for all patients. Radiation Therapy was delivered on ipsilateral lymph node areas in 62 cases (44%: UL-RT group) and on bilateral lymph node areas and the entire pharyngeal mucosa in 77 cases (56%: COMP-RT group). Impact of radiation modalities on locoregional control and overall survival was assessed using propensity score matching method in order to balance baseline characteristics between the two groups. The population included 80.4% men, 80.4% smokers, 32.6% P16 positive tumours and 71.0% extracapsular extension. After a median follow-up of 5 years, the locoregional control rate was 80.3% in the UL-RT group and 75.3% in the COMP-RT group (p = 0.688). The corresponding rate of contralateral lymph node recurrence was 0% versus 2.6% (p = 0.503) and the rate of tumour emergence was 11.5% versus 9.1% (p = 0.778). No significant difference was observed between the UL-RT and the COMP-RT groups for overall survival (p = 0.9516), specific survival (p = 0.4837) or tumour emergence (p = 0.9034). UL-RT seems to provide similar outcomes as COMP-RT in unilateral HNCUP post-operative management.

Identifiants

pubmed: 33845043
pii: S0167-8140(21)06183-1
doi: 10.1016/j.radonc.2021.04.002
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Esteban Brenet (E)

Head and Neck Surgery Department, Centre Hospitalo Universitaire Reims, France.

Pierre Philouze (P)

Head and Neck Surgery Department, Centre Hospitalo Universitaire Lyon Sud, France.

Camille Schiffler (C)

Biostatistics Deparment, Centre Léon Bérard, Lyon, France.

Pascal Pommier (P)

Radiotherapy Department, Centre Léon Bérard, Lyon, France.

Carole Crozes (C)

Pathological Anatomy Department, Centre Léon Bérard, Lyon, France.

Nazim Benzerdjeb (N)

Pathological Anatomy Department, Centre Hospitalo Universitaire Lyon Sud, France.

Elodie Monchet (E)

Head and Neck Surgery Department, Centre Oscar Lambret, Lille, France.

Camille Boulagnon-Rombi (C)

Pathological Anatomy Department, Centre Hospitalo Universitaire Reims, France.

Jean Ton Van (J)

Head and Neck Department, Centre Oscar Lambret, Lille, France.

Fabien Podeur (F)

Oncologic Surgery Department, Centre Léon Bérard, Lyon, France.

Stéphanie Servagi-Vernat (S)

Radiotherapy Department, Institut Godinot, Reims, France.

Xavier Liem (X)

Radiotherapy Department, Centre Oscar Lambret, Lille, France.

Jean-Claude Merol (JC)

Head and Neck Department, Centre hospilato Universitaire Reims, France.

Philippe Ceruse (P)

Head and Neck Surgery Department, Centre Hospitalo Universitaire Lyon Sud, France.

Anne-Agathe Serre (AA)

Radiotherapy Department, Centre Léon Bérard, Lyon, France.

Sylvie Chabaud (S)

Biostatistics Department, Centre Léon Bérard, Lyon, France.

Morbize Julieron (M)

Head and Neck Surgery Department, Centre Oscar Lambret, Lille, France.

Sophie Deneuve (S)

Oncologic Surgery Department, Centre Léon Bérard, Lyon, France. Electronic address: fdeneuve@club.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH